Literature DB >> 19891906

Emergency treatment of acute ischemic stroke: expanding the time window.

Raul G Nogueira1, Wade S Smith.   

Abstract

Intravenous thrombolysis has been shown to improve outcome in patients with ischemic stroke if given within the first 3 hours. This benefit extends into a 4.5-hour time window when applied in a more selected patient population. Strokes from large-vessel intracranial occlusion carry high morbidity and respond poorly to intravenously administered thrombolytics. Endovascular therapy should therefore be considered in patients who fail or have contraindications for intravenous thrombolysis, or who present within a time window of 4.5 to 8 hours, and perhaps up to 12 to 24 hours for basilar occlusions.

Entities:  

Year:  2009        PMID: 19891906     DOI: 10.1007/s11940-009-0047-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  44 in total

1.  Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I.

Authors:  W S Smith
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

2.  Time is brain--quantified.

Authors:  Jeffrey L Saver
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

3.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.

Authors:  Anthony J Furlan; Dirk Eyding; Gregory W Albers; Yasir Al-Rawi; Kennedy R Lees; Howard A Rowley; Christian Sachara; Mariola Soehngen; Steven Warach; Werner Hacke
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

4.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

5.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

6.  Imaging-based thrombolysis trial in acute ischemic stroke-II (ITAIS-II).

Authors:  Yilong Wang; Xiaoling Liao; Xingquan Zhao; Chunxue Wang; Liping Liu; Yong Zhou; Chunjuan Wang; Jing Xue; Peiyi Gao; Kehui Dong; Xunming Ji; Yongjun Wang
Journal:  Int J Stroke       Date:  2009-02       Impact factor: 5.266

7.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

8.  Methodology of the Interventional Management of Stroke III Trial.

Authors:  Pooja Khatri; Michael D Hill; Yuko Y Palesch; Judith Spilker; Edward C Jauch; Janice A Carrozzella; Andrew M Demchuk; Renee' Martin; Patrick Mauldin; Catherine Dillon; Karla J Ryckborst; Scott Janis; Thomas A Tomsick; Joseph P Broderick
Journal:  Int J Stroke       Date:  2008-05       Impact factor: 5.266

9.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

10.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

View more
  2 in total

1.  Interfacility helicopter ambulance transport of neurosurgical patients: observations, utilization, and outcomes from a quaternary level care hospital.

Authors:  Brian P Walcott; Jean-Valery Coumans; Matthew K Mian; Brian V Nahed; Kristopher T Kahle
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

2.  CT perfusion-guided patient selection for endovascular recanalization in acute ischemic stroke: a multicenter study.

Authors:  Aquilla S Turk; Jordan Asher Magarick; Don Frei; Kyle Michael Fargen; Imran Chaudry; Christine A Holmstedt; Joyce Nicholas; J Mocco; Raymond D Turner; Daniel Huddle; David Loy; Richard Bellon; Gwendolyn Dooley; Robert Adams; Michelle Whaley; Chris Fanale; Edward Jauch
Journal:  J Neurointerv Surg       Date:  2012-11-26       Impact factor: 5.836

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.